GEP has had a clear impact on elucidating ALK negative ALCL biology, defining the borders with other PTCL subtypes and providing new genomic classifiers for the correct stratification of patients. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.